Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT06264505
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Soft Tissue Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Generally, specific demographic cohorts exhibit higher participation rates in medical research, yet there exists a scarcity of research elucidating the trial attributes impacting the engagement of these particular demographics. The primary objective of this study is to gather extensive data on the clinical trial experiences of individuals diagnosed with soft tissue sarcoma, with the aim of identifying factors hindering patient enrollment or trial completion.
Key Dates
- Start date
- Mar 31, 2025
- Status verified
- Feb 2024
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Rate of patients in soft tissue sarcoma clinical research [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill(415) 900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 |
Find similar trials in San Francisco, CA
Related Studies
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)PHASE3 · Recruiting · Polaris Group · Phoenix, Arizona
- 5-Day Preoperative Radiation for Soft Tissue SarcomaPHASE2 · Recruiting · Stanford University · Palo Alto, California
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Tanabe Pharma America, Inc. · Los Angeles, California